Skip to main content
×
×
Home

Antipsychotic medication in learning disability Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit

  • Sherva E. Cooray (a1) and Jovanka Tolmac (a1)
Abstract
Aims and method

Antipsychotic medication, an effective treatment modality in the management of psychiatric/behaviour disorders in people with learning disability, is often criticised because of poor clinical practice. Rational and judicious use, subject to evidence-based guidelines and systematic monitoring, is mandatory. A five-year clinical audit programme on the quality of prescribing for this clientele was undertaken.

Results

Significant quality improvement with minimal resource consumption was demonstrated.

Clinical implications

Clinical audit facilitates high-quality prescribing: pragmatic and economic, it can easily be integrated into routine clinical practice.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antipsychotic medication in learning disability Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antipsychotic medication in learning disability Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antipsychotic medication in learning disability Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Correspondence
References
Hide All
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Bethlem & Maudsley NHS Trust (1995) Prescribing Guidelines (2nd edn. 2nd impression), Appendix 1, pp. 2122. London: Bethlem and Maudsley NHS Trust.
Brylewski, J. & Duggan, L. (1996) Antipsychotic medication for challenging behaviour in people with learning disability (Protocol). In Schizophrenia Module (eds Adams, C. E., Duggan, C., de Jesus Mari, J., et al) The Cochrane Database of Systematic Reviews (available in the Cochrane Library). London: BMJ Publishing.
Deb, S. & Fraser, W. (1994) The use of psychotropic medication in people with learning disability: towards rationale prescribing. Human Psychopharmacology, 9, 259272.
Einfeld, S. L. (1990) Guidelines for use of psychotropic medication in individuals with developmental disabilities. Australia and New Zealand Journal of Developmental Disabilities, 16, 7173.
Fan, T. W. (1991) Prescribing in mental handicap hospitals. British Journal of Psychiatry, 158, 282292.
Foster, R. P. (1989) Neuroleptic equivalence. Pharmaceutical Journal, 243, 431432.
Gravestock, S. (1994) Quality assurance for adults with mental retardation and mental health needs. In Mental Health Needs in Mental Retardation (ed. Bouras, N.), pp. 319327. Cambridge: Cambridge University Press.
Gualtieri, C. T. (1990) Neuropsychiatry and Behavioural Psychopharmacology. Berlin: Springer-Verlag.
Harvey, R. J. & Cooray, S. E. (1993) Neuroleptic usage in a community mental handicap unit. Psychiatric Bulletin, 17, 657660.
Hempel, C. G. (1961) Introduction to problems of taxonomy. In Field Studies in the Mental Disorders (ed. Zubin, J.). New York: Grune and Stratton.
Holbrook, J. M., Parks-Veal, P. & Mimbs, J. (1991) Clinical monitoring guidelines for neuroleptic and antidepressant drugs. Hospital Pharmacy, 26, 783784, 787–793.
Joffe, R. T. & Calabrese, J. R. (eds) (1994) Anticonvulsants in Mood Disorders. New York: Marcel Dekker.
Matson, J. L., Kazden, A. E. & Sentore, V. (1984) Psychometric properties of the Psychopathology Instrument for Mentally Retarded Adults. Applied Research - Mental Retardation, 5, 8189.
Matson, J. L., Gardner, W. I., Koe, D. A., et al (1991) A scale for evaluating emotional disorders in severely and profoundly retarded persons: Development of the Diagnostic Assessment for the Severely Handicapped (DASH) scales. British Journal of Psychiatry, 159, 404429.
Paton, C. & Beer, D. (1996) Blood tests for patients prescribed psychotropics: what, when and why. Psychiatric Bulletin, 20, 356358.
Royal College of Psychiatrists (1993) Consensus Statement on the Use of High Dose Antipsychotic Medication (Council Report CR26). London: Royal College of Psychiatrists.
Sachdev, P. S. (1991) Psychoactive drug use in an institution for intellectually handicapped persons. Medical Journal of Australia, 155, 7579.
Sovner, R. (1989) Treating mentally retarded adults with psychotropic drugs: a clinical perspective. In Mental Retardation and Mental Illness (eds Fletcher, R. & Menolascino, F. J.). pp. 157183. Lexington, MA: Lexington Books.
Sovner, R. (1991) Use of anticonvulsant agents for the treatment of neuropsychiatric disorders in the developmentally disabled. In Mental Retardation: Developing Pharmacotherapies (ed. Ratey, J. J.). pp. 83106. Washington, DC: American Psychiatric Press.
Sovner, R. & Lowry, M. A. (1995) Pharmacological treatment of chronic behavioural problems in persons with mental retardation. In Research Pharmacological Management of Chronic Psychiatric Disorders (eds Ancill, R. J. & Lader, M. H.) in Baillière's Clinical Psychiatry, pp. 683703. London: Baillière Tindall Harcourt.
Tohen, M., Castillo, J., Baldessarini, R., et al (1995) Blood dyscrasias with carbamazepine and valproate: A pharmacological study of 2228 patients at risk. American Journal of Psychiatry, 145, 339342.
World Health Organization (1992) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10). Geneva: WHO.
Wressell, S. E., Tyrer, S. P. & Berney, T. P. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients: a hospital study. British Journal of Psychiatry, 157, 101106.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 3 *
Loading metrics...

Abstract views

Total abstract views: 16 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 20th July 2018. This data will be updated every 24 hours.

Antipsychotic medication in learning disability Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit

  • Sherva E. Cooray (a1) and Jovanka Tolmac (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *